тип : |
Лаборатория |
|
Исследовательские группы : |
|
Авторы : |
|
Заголовок : |
Avelumab (Bavencio®) - Summary of Product Characteristics |
Номер : |
Merck 2023 |
|
Уровень доказательности : |
|
Физическая стабильность : |
|
Химическая стабильность : |
|
Другие методы : |
|
Комментарии : |
|
Списки
Avelumab
|
|
|
|
|
3.2 mg/mL |
2-8°C |
|
96 |
|
|
|
|
|
|
3.2 mg/mL |
20-25°C |
|
72 |
|
|
|
|
|
|
3.2 mg/mL |
2-8°C |
|
24 |
|
|
|
|
|
|
3.2 mg/mL |
20-25°C |
|
24 |
|
|
|
|
|
|
3.2 mg/mL |
2-8°C |
|
96 |
|
|
|
|
|
|
3.2 mg/mL |
20-25°C |
|
72 |
|
|
|
|
|
|
3.2 mg/mL |
2-8°C |
|
24 |
|
|
|
|
|
|
3.2 mg/mL |
20-25°C |
|
24 |
|
|
|
|
|
|
3.2 mg/mL |
2-8°C |
|
96 |
|
|
|
|
|
|
3.2 mg/mL |
20-25°C |
|
72 |
|
|
|
|
|
|
3.2 mg/mL |
2-8°C |
|
24 |
|
|
|
|
|
|
3.2 mg/mL |
20-25°C |
|
24 |
|
|
|
|
|
|
3.2 mg/mL |
2-8°C |
|
96 |
|
|
|
|
|
|
3.2 mg/mL |
20-25°C |
|
72 |
|
|
|
|
|
|
3.2 mg/mL |
2-8°C |
|
24 |
|
|
|
|
|
|
3.2 mg/mL |
20-25°C |
|
24 |
|
|
|
|
|
|
3.2 mg/mL |
2-8°C |
|
96 |
|
|
|
|
|
|
3.2 mg/mL |
20-25°C |
|
72 |
|
|
|
|
|
|
3.2 mg/mL |
2-8°C |
|
24 |
|
|
|
|
|
|
3.2 mg/mL |
20-25°C |
|
24 |
|
|
|
|
|